Lost Ozempic Access? GLP-1 Alternatives for Weight Loss and Weight Maintenance

Staff
By Staff
4 Min Read

Some GLP-1 users have been able to win back coverage by pursuing every possible option in the confusing world of healthcare.

Appeal Lost Coverage

Bridget Roberts, 37, was reapproved for Zepbound by remaining patient and persistent. It started when the Pottsgrove, Pennsylvania, resident received a letter that her insurance company was no longer covering the GLP-1.

“Initially, I felt I was doomed,” she says. “Something was finally working for me, and I was more alive than ever, and they wanted to take it from me.”

Roberts pushed back. She called to appeal repeatedly, getting a different story each time. Her persistence finally paid off. She spoke to someone from the insurance company who told her to ask her doctor for a new prior authorization, a type of preapproval request that an insurance company sometimes requires doctors to submit before agreeing to cover a treatment. “It was like she was talking in code, like she knew something I didn’t,” Roberts says. She and her doctor were equally confused because she already had a prior authorization, but when the doctor put in the new request, her medication was approved.

Switch Diagnoses

Other GLP-1 users have successfully retained coverage by changing the diagnosis indicated on their prescriptions.

“Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations,” says Supriya Rao, MD, a gastroenterologist and obesity expert at Integrated Gastroenterology Consultants in Boston.

If your insurer canceled coverage for a weight loss medication, it is possible that it will cover the same medication for a different condition, such as sleep apnea or heart disease. A new prescription for a new condition “can make the difference between full denial and full coverage,” says Dr. Rao.

Brianna Johnson-Rabbett, MD, an endocrinologist with Nebraska Medicine and a director of the American Board of Obesity Medicine, offers some examples. “If someone has established cardiovascular disease and is obese or overweight, Wegovy can be prescribed under that indication,” Dr. Johnson-Rabbett says. “If someone has moderate to severe obstructive sleep apnea and obesity, Zepbound can be prescribed for that indication.”

Switching diagnoses is no guarantee of coverage, however. “Insurance still may decide not to cover a medication, even if FDA indications for prescribing that medication are met,” says Johnson-Rabbett.

Search for Discounts

A variety of discounts may be available from the manufacturers.

The makers of Wegovy and Zepbound offer coupons and savings cards that can considerably lower your out-of-pocket cost for as long as one year. Not everyone qualifies for these programs, however, and they cannot be used indefinitely.

The two GLP-1 makers have also begun to offer discounts to users who pay in cash directly. These programs, which cost about $500 per month, may require the use of a vial and syringe, as opposed to the auto-injector pens.

Read the full article here

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *